English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 9, 2026

Saol Therapeutics resubmits rare disease drug application to FDA with new survival data
+ Pharmaceuticals
Patient Daily | Jul 9, 2026

Study finds ear acupuncture may ease migraine pain but shows no clear superiority over sham
+ Pharmaceuticals
Patient Daily | Jul 9, 2026

Researchers develop noninvasive method to analyze compounds released during cupping therapy
+ Pharmaceuticals
Patient Daily | Jul 9, 2026

Study finds ADHD remains underdiagnosed in England despite recent increases
+ Pharmaceuticals
Patient Daily | Jul 9, 2026

UCSF and Samsung begin remote study to track aging brain health with wearables
+ Pharmaceuticals
Patient Daily | Jul 8, 2026

Study finds socioeconomic status affects metabolic disease rates differently across racial groups
+ Pharmaceuticals
Patient Daily | Jul 8, 2026

Illinois emergency departments face challenges in pediatric mental health crisis care
+ Pharmaceuticals
Patient Daily | Jul 8, 2026

Biopharma sees selective recovery as major VC rounds mark H1 2026

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes